Table_5.xls (5.5 kB)
Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.
dataset
posted on 2015-09-30, 03:08 authored by Tian-Xiao Li, Bu-Lang Gao, Dong-Yang Cai, Zi-Liang Wang, Liang-Fu Zhu, Jiang-Yu Xue, Wei-Xing Bai, Ying-Kun He, Li LiNote:
# The disabling or fatal stroke rates within 30 days could be found in Table 3 in reference 8.
* The disabling or fatal stroke rates at the end of 32.4 months of follow-up for both groups could be found in Table 3 in reference 9.
** The number of patients with disabling or fatal stroke beyond 30 days was 21–16 = 5 for the PTAS group but 18–4 = 14 for the MED group, whereas the number of patients who finished the follow-up was 191 for the PTAS group and 210 for the MED group (see the Results of reference 9). PTAS: percutaneous transluminal angioplasty and stenting; MED: medical management group.
Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.
